Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain.
Silbergleit
Robert
R
Scott
Phillip A
PA
D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator